Stockscreener 앱 받기
12.45
0.48%
0.06
전일 마감가:
$12.39
열려 있는:
$12.4
하루 거래량:
474.99K
Relative Volume:
0.58
시가총액:
$571.26M
수익:
$524.73M
순이익/손실:
$31.70M
주가수익비율:
18.82
EPS:
0.6617
순현금흐름:
$22.47M
1주 성능:
+9.69%
1개월 성능:
+7.79%
6개월 성능:
-32.92%
1년 성능:
+17.45%
1일 변동 폭
$12.29
$12.85
1주일 범위
$11.37
$12.85
52주 변동 폭
$9.79
$20.36
Core Laboratories Inc Stock (CLB) Company Profile
Compare CLB vs SLB, BKR, FTI, HAL, TS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLB
Core Laboratories Inc
|
12.45 | 571.26M | 524.73M | 31.70M | 22.47M | 0.6617 |
SLB
Slb Ltd
|
53.77 | 78.07B | 35.91B | 3.38B | 4.41B | 2.2806 |
BKR
Baker Hughes Company
|
64.82 | 63.81B | 27.89B | 3.15B | 2.29B | 3.1363 |
FTI
Technipfmc Plc
|
78.61 | 29.52B | 10.17B | 1.08B | 1.34B | 2.6138 |
HAL
Halliburton Co
|
34.42 | 27.73B | 22.37B | 1.61B | 1.73B | 1.9091 |
TS
Tenaris Sa Adr
|
53.58 | 26.83B | 12.19B | 2.03B | 1.87B | 3.8072 |
Core Laboratories Inc Stock (CLB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-12 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-06-30 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2023-04-18 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-01-09 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-10-07 | 업그레이드 | Citigroup | Sell → Neutral |
| 2022-09-26 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-04-18 | 다운그레이드 | Piper Sandler | Neutral → Underweight |
| 2021-10-18 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-07-09 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-14 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2020-12-18 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-11-11 | 재확인 | Cowen | Market Perform |
| 2020-10-13 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2020-09-29 | 업그레이드 | ABN Amro | Sell → Hold |
| 2020-07-16 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2020-04-13 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2020-03-09 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2020-03-09 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-01-31 | 재확인 | Cowen | Market Perform |
| 2020-01-30 | 재개 | Johnson Rice | Buy |
| 2020-01-14 | 개시 | Bernstein | Mkt Perform |
| 2020-01-02 | 다운그레이드 | Stifel | Buy → Hold |
| 2019-12-31 | 재확인 | Cowen | Market Perform |
| 2019-07-10 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-02-25 | 업그레이드 | Tudor Pickering | Hold → Buy |
| 2018-12-19 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2018-12-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-11-16 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2018-11-01 | 업그레이드 | ABN Amro | Sell → Buy |
| 2018-10-29 | 재확인 | Cowen | Market Perform |
모두보기
Core Laboratories Inc 주식(CLB)의 최신 뉴스
Disciplined Growth Investors (CLB) reports 6.6% Core Laboratories stake on Schedule 13G/A - Stock Titan
Ariel Investments (CLB) discloses 30.5% Core Laboratories stake in Schedule 13G/A - Stock Titan
Core Laboratories (NYSE:CLB) Stock Rating Upgraded by Johnson Rice - marketbeat.com
Core Laboratories Inc. (CLB) stock price, news, quote and history - Yahoo Finance Australia
Core Laboratories Inc. (HJ1.F) stock price, news, quote and history - Yahoo Finance UK
Core Laboratories N.V. (CLB) stock price, news, quote and history - Yahoo Finance UK
Core Laboratories' (NYSE:CLB) Weak Earnings May Only Reveal A Part Of The Whole Picture - webull.com
Core Laboratories (CLB) Q2 2026 Earnings Call Transcript - The Globe and Mail
Core Laboratories Inc (CLB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Dimensional Fund Advisors LP Increases Stock Position in Core Laboratories Inc. $CLB - marketbeat.com
BlackRock (CLB holder) discloses 8.3% beneficial stake in Core Laboratories Inc - Stock Titan
Core Laboratories Inc (CLB) Chairman and CEO Lawrence Bruno Buys 5,000 Shares - GuruFocus
Core Laboratories (NYSE:CLB) CEO Lawrence Bruno Buys 5,000 Shares - marketbeat.com
Core Laboratories (NYSE: CLB) CEO purchases 5,000 shares in open-market trade - Stock Titan
Core Laboratories CAO Teo Sow Hang Reports Vesting of Restricted Shares and Tax Withholding Disposals - Kalkine Media
Core Laboratories (NYSE:CLB) Rating Increased to Hold at Wall Street Zen - marketbeat.com
Core Laboratories Q2 Earnings Call Highlights - marketbeat.com
Core Lab Q2 earnings miss analyst estimates By Investing.com - Investing.com Canada
Why Is Core Laboratories (NYSE:CLB) in NYSE Composite News Flow? - Kalkine Media
Core Laboratories (CLB) Q2 Earnings Surpass Estimates - Yahoo Finance Singapore
Core Laboratories Inc reports results for the quarter ended June 30Earnings Summary - tradingview.com
Core Laboratories: Q2 Earnings Snapshot - 10TV
Core Laboratories (NYSE:CLB) Misses Q2 CY2026 Sales Expectations - The Globe and Mail
Press Release: CORE LAB REPORTS SECOND QUARTER 2026 RESULTS - Moomoo
Core Laboratories (NYSE: CLB) posts Q2 profit, buybacks and Q3 guidance - Stock Titan
Core Laboratories Q2 adj EPS $0.11 beats estimate - scanx.trade
Core Laboratories (CLB) Q2 Earnings Report Preview: What To Look For - Yahoo Finance
CLB|Core Laboratories Inc|Price:11.230|Chg%:-0.440 - TradingKey
Core Laboratories Inc expected to post earnings of 9 cents a shareEarnings Preview - TradingView
Core Laboratories Inc (CLB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Core Laboratories Inc (CLB) Income Statement - TradingKey
Core Laboratories Inc (CLB) Cash Flow - TradingKey
Core Laboratories Inc (CLB) Institutional Confidence - tradingkey.com
Core Laboratories Inc (CLB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Core Laboratories Inc (CLB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Core Laboratories Inc (CLB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CLB|Core Laboratories Inc|Price:12.100|Chg%:+0.750 - tradingkey.com
Core Laboratories Inc (CLB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CLB|Core Laboratories Inc|Price:11.690|Chg%:-0.110 - TradingKey
Core Laboratories Inc (CLB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
What's in Store for Core Laboratories Stock in Q2 Earnings? - Zacks Investment Research
Siemens Healthineers Launches an Industry-leading Menu for Core Lab Capillary Testing on Atellica Analyzers with Claims for 24 Assays - Siemens Healthineers
Core Laboratories (NYSE:CLB) Trading Up 5.9%Here's What Happened - MarketBeat
Earnings Preview: Core Laboratories (CLB) Q2 Earnings Expected to Decline - Yahoo Finance
Core Laboratories (CLB) Expected to Release Earnings on Wednesday - MarketBeat
Are Options Traders Betting on a Big Move in Core Laboratory Stock? - TradingView
Core Stock Down 39% in 6 Months: Should You Hold or Sell Now? - Yahoo Finance
Heartland Advisors Inc. Makes New $2.52 Million Investment in Core Laboratories Inc. $CLB - MarketBeat
Weekly Recap: Pivotal trial, approvals and Core lab and cancer gains - TradingView
What is Zacks Research's Estimate for CLB FY2027 Earnings? - MarketBeat
Abbott Laboratories Q2 Earnings Call Highlights - TradingView
Core Laboratories Inc (CLB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Core Laboratories Inc 주식 (CLB) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Teo Sow Hang | CAO & Treasurer |
Aug 01 '26 |
Option Exercise |
0.00 |
440 |
0 |
8,775 |
| Tattoli Mark Damian | SVP, Gen Counsel & Secretary |
Aug 01 '26 |
Option Exercise |
0.00 |
250 |
0 |
27,764 |
| Tattoli Mark Damian | SVP, Gen Counsel & Secretary |
May 01 '26 |
Option Exercise |
0.00 |
250 |
0 |
27,611 |
| Murray Katherine | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
8,069 |
0 |
29,290 |
| ANASTASIO CURT | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
8,069 |
0 |
23,805 |
| Klingensmith Harvey Robert | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
8,069 |
0 |
50,031 |
| Temeng Kwaku | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
8,069 |
0 |
33,597 |
| MARTINOVICH ROBERT F | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
8,069 |
0 |
8,069 |
| Carnes Martha Z. | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
8,069 |
0 |
54,397 |
| Tattoli Mark Damian | SVP, Gen Counsel & Secretary |
Dec 31 '25 |
Option Exercise |
0.00 |
24,952 |
0 |
41,671 |
1.72%
자본화:
|
볼륨(24시간):